Glow 70MG

Product Overview

Glow 70MG is a three-component lyophilised blend containing GHK-Cu, BPC-157 and TB-500, supplied as blue lyophilised powder in a 70mg catalogue presentation (SKU BBG70). This page describes the stated research identity and batch-oriented catalogue specification; it does not provide an administration protocol.

Glow combines three materials with separate preclinical literatures involving copper-peptide chemistry, cell migration, extracellular-matrix responses and actin-associated pathways. Individual-component evidence does not validate the combined formulation.

Identity and Specifications

• Product: Glow 70MG
• SKU: BBG70
• Format: Blue lyophilised powder
• Synonyms: Glow Blend, GHK-Cu + BPC-157 + TB-500
• Composition: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg
• Component verification: See linked Janoshik COA
• Total amount: 70mg

Research Context

The following themes summarise published research on the named molecule or components. They are research contexts, not claims about the supplied ExtolX batch.

Areas of Research

• component identity, amount and ratio verification
• copper-peptide and matrix-signalling models
• fibroblast, migration and angiogenesis assays
• combined-formulation solubility, compatibility and stability

Evidence Quality and Limitations

Direct evidence for the three-component blend is limited. No additive, synergistic, cosmetic or therapeutic effect should be inferred from studies of the individual components.

Storage and Handling

Before reconstitution: Keep the sealed lyophilised blend dry and protected from light at −20°C or below, subject to the batch-specific supplier documentation. Storage data for GHK-Cu, BPC-157 and TB-500 do not establish the stability of the combined Glow formulation. Protect the blue material from contamination and investigate any unexpected colour or particulate change.

After reconstitution: No reliable combined-formulation stability period has been verified. Do not infer a hold time from any one component. Validate the solvent, concentration, pH, container, temperature and hold time for the complete blend. Where the validated method supports frozen storage, use single-use aliquots and avoid vigorous agitation and repeated freeze–thaw cycles. Record the preparation and storage history.

Compatibility Limitations

Do not infer solubility or stability from another peptide, blend, amount or pharmaceutical formulation. Use small-scale method development and appropriate analytical controls before committing valuable material.

Laboratory Safety

Handle only in an appropriately equipped laboratory by trained personnel. Use a task-specific risk assessment, suitable personal protective equipment and applicable safety documentation. Avoid ingestion, inhalation, skin contact and environmental release, and dispose of waste in accordance with local requirements.

Sources

• Technical storage references for the components: GHK-Cu, BPC-157 and TB-500
• PubMed: GHK-Cu regenerative and protective actions
• PubMed: BPC-157 and tendon-fibroblast migration
• PubMed: Characterisation of the TB-500 fragment
• PubMed: GHK as a cellular gene-expression modulator
• PubMed: BPC-157 preclinical research
• PubMed: Thymosin beta-4 biological activities

Scientific sources last reviewed: 23 August 2026.

Research Use Agreement & Disclaimer

For laboratory research use only. Not for human or veterinary use. Purchasers are responsible for lawful handling, storage and disposal in accordance with applicable regulations and good laboratory practice. Product information is educational and is not medical advice or evidence of efficacy.